Al-Abd, 2017, Anti-angiogenic agents for the treatment of solid tumors: potential pathways, therapy and current strategies – a review, J. Adv. Res., 8, 591, 10.1016/j.jare.2017.06.006
Badimon, 2018, Microvasculature recovery by angiogenesis after myocardial infarction, Curr. Pharm. Des., 24, 2967, 10.2174/1381612824666180629162726
Baulina, 2022, Circulating miR-499a-5p is a potential biomarker of MYH7—associated hypertrophic cardiomyopathy, Int. J. Mol. Sci., 23, 3791, 10.3390/ijms23073791
Chen, 2019, Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma, J. Exp. Clin. Cancer Res., 38, 466, 10.1186/s13046-019-1436-0
Chen, 2020, Tanshinone IIA alleviates hypoxia/reoxygenation induced cardiomyocyte injury via lncRNA AK003290/miR-124-5p signaling, BMC Mol. Cell. Biol., 21, 20, 10.1186/s12860-020-00264-3
Du, 2018, Hypoxia-inducible factor 1 alpha (HIF-1alpha)/Vascular endothelial growth factor (VEGF) pathway participates in angiogenesis of myocardial infarction in muscone-treated mice: preliminary study, Med. Sci. Monit., 24, 8870, 10.12659/MSM.912051
Fu, 2019, Inhibition of miR-495 improves both vascular remodeling and angiogenesis in pulmonary hypertension, J. Vasc. Res., 56, 97, 10.1159/000500024
Gao, 2019, Effects of the combination of tanshinone IIA and puerarin on cardiac function and inflammatory response in myocardial ischemia mice, J. Mol. Cell. Cardiol., 137, 59, 10.1016/j.yjmcc.2019.09.012
Geng, 2020, Exosome derived from coronary serum of patients with myocardial infarction promotes angiogenesis through the miRNA-143/IGF-IR pathway, Int. J. Nanomedicine, 15, 2647, 10.2147/IJN.S242908
Goradel, 2018, Stem cell therapy: a new therapeutic option for cardiovascular diseases, J. Cell. Biochem., 119, 95, 10.1002/jcb.26169
Guo, 2018, Panax quinquefolium saponins attenuate myocardial dysfunction induced by chronic ischemia, Cell. Physiol. Biochem., 49, 1277, 10.1159/000493407
Hu, 2018, Knockdown of lncRNA MALAT1 attenuates acute myocardial infarction through miR-320-Pten axis, Biomed. Pharmacother., 106, 738, 10.1016/j.biopha.2018.06.122
Huang, 2020, Exosomes derived from miR-126-modified MSCs promote angiogenesis and neurogenesis and attenuate apoptosis after spinal cord injury in rats, Neuroscience, 424, 133, 10.1016/j.neuroscience.2019.10.043
Jeong, 2021, Pathological angiogenesis and inflammation in tissues, Arch. Pharm. Res., 44, 1, 10.1007/s12272-020-01287-2
Jung, 2017, Exosomes generated from iPSC-derivatives: new direction for stem cell therapy in human heart diseases, Circ. Res., 120, 407, 10.1161/CIRCRESAHA.116.309307
Lee, 2017, Tanshinone IIA inhibits angiogenesis in human endothelial progenitor cells in vitro and in vivo, Oncotarget, 8, 10.18632/oncotarget.22649
Li, 2018, Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics, Acta Pharmacol. Sin., 39, 802, 10.1038/aps.2017.193
Li, 2018, Tanshinone IIA and astragaloside IV promote the angiogenesis of mesenchymal stem cell-derived endothelial cell-like cells via upregulation of Cx37, Cx40 and Cx43, Exp. Ther. Med., 15, 1847
Li, 2021, Natural products: a promising therapeutics for targeting tumor angiogenesis, Front. Oncol., 11
Ma, 2018, MicroRNA-132, delivered by mesenchymal stem cell-derived exosomes, promote angiogenesis in myocardial infarction, Stem Cells Int., 2018, 10.1155/2018/3290372
Moussa, 2013, Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI), J. Am. Coll. Cardiol., 62, 1563, 10.1016/j.jacc.2013.08.720
Mouton, 2018, Myocardial infarction remodeling that progresses to heart failure: a signaling misunderstanding, Am. J. Physiol. Heart Circ. Physiol., 315, H71, 10.1152/ajpheart.00131.2018
Oka, 2014, Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure, Circ. Res., 114, 565, 10.1161/CIRCRESAHA.114.300507
Paneni, 2017, The aging cardiovascular system: understanding it at the cellular and clinical levels, J. Am. Coll. Cardiol., 69, 1952, 10.1016/j.jacc.2017.01.064
Reed, 2017, Acute myocardial infarction, Lancet, 389, 197, 10.1016/S0140-6736(16)30677-8
Saliminejad, 2019, An overview of microRNAs: biology, functions, therapeutics, and analysis methods, J. Cell. Physiol., 234, 5451, 10.1002/jcp.27486
Sui, 2017, Tanshinone IIA inhibits beta-catenin/VEGF-mediated angiogenesis by targeting TGF-beta1 in normoxic and HIF-1alpha in hypoxic microenvironments in human colorectal cancer, Cancer Lett., 403, 86, 10.1016/j.canlet.2017.05.013
Toraih, 2017, Structure and functional impact of seed region variant in MIR-499 gene family in bronchial asthma, Respir. Res., 18, 169, 10.1186/s12931-017-0648-0
Wang, 2020, MicroRNA-499 suppresses the growth of hepatocellular carcinoma by downregulating astrocyte elevated Gene-1, Technol. Cancer Res. Treat., 19
Xin, 2016, Circulating miR-499 as a potential biomarker for acute myocardial infarction, Ann. Transl. Med., 4, 10, 10.21037/atm.2016.03.40
Yehia, 2020, The clinical spectrum of PTEN mutations, Annu. Rev. Med., 71, 103, 10.1146/annurev-med-052218-125823
Zhou, 2018, miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges, Acta Pharmacol. Sin., 39, 1073, 10.1038/aps.2018.30